Efficacy of Rituximab in the Treatment of Pemphigus Vulgaris: A Meta-analysis
Efficacy of Rituximab in the Treatment of Pemphigus Vulgaris: A Meta-analysis
About this item
Full title
Author / Creator
Cai, Yanxia , Liu, Yaqin , Deng, Shiyin , Luo, Yaqi and Deng, Liehua
Publisher
United States: InnoVision Health Media, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: InnoVision Health Media, Inc
Subjects
More information
Scope and Contents
Contents
Pemphigus vulgaris (PV) accounts for about 80% of all patients with pemphigus, and is the type with the most serious condition and the worst prognosis among autoimmune bullous diseases. Glucocorticoid and immunosuppressor are the main treatment method for PV.
The computer retrieves four databases obtain controlled trials on the effects of Rituxi...
Alternative Titles
Full title
Efficacy of Rituximab in the Treatment of Pemphigus Vulgaris: A Meta-analysis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_3117070807
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3117070807
Other Identifiers
ISSN
1078-6791
